APPLIED GENETIC TECHNOLOGIES (AGTC) Forecast, Price Target & Analyst Ratings

Q: Can you provide the average price target for APPLIED GENETIC TECHNOLOGIES stock?

10 analysts have analysed AGTC and the average price target is 0.37 USD. This implies a price decrease of -6.71% is expected in the next year compared to the current price of 0.3936.

NASDAQ:AGTC • US03820J1007

0.3936 USD

+0 (+1.23%)

At close: Nov 30, 2022

0.3936 USD

0 (0%)

After Hours: 11/30/2022, 8:18:22 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APPLIED GENETIC TECHNOLOGIES (AGTC).

Consensus Price Target

Price Target

$0.37

-6.71% Downside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: Feb 13, 2023
Period: Q2 / 2023
EPS Estimate: -$0.19
Revenue Estimate

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

50.00%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$0.37

Upside

-6.71%

From current price of $0.39 to mean target of $0.37, Based on 10 analyst forecasts

Low

$0.34

Median

$0.35

High

$0.42

Price Target Revisions

1 Month

1.41%

3 Months

N/A

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for AGTC. The average price target is 0.37 USD. This implies a price decrease of -6.71% is expected in the next year compared to the current price of 0.3936.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

50.00%

AGTC was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about AGTC.

In the previous month the buy percentage consensus was at a similar level.

AGTC was analyzed by 10 analysts. More opinions would make the average more meaningful.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2022-10-25	Wells Fargo	Maintains	Equal-Weight
2022-10-25	HC Wainwright & Co.	Downgrade	Buy -> Neutral
2022-10-24	Stifel	Downgrade	Buy -> Hold
2022-10-24	Wedbush	Downgrade	Outperform -> Neutral
2022-10-04	Wells Fargo	Downgrade	Overweight -> Equal-Weight
2022-09-30	Stifel	Maintains	Buy
2022-09-30	HC Wainwright & Co.	Maintains	Buy
2022-09-29	BTIG	Downgrade	Buy -> Neutral
2022-09-28	Chardan Capital	Maintains	Buy
2022-05-18	Chardan Capital	Maintains	Buy
2021-06-15	BTIG	Initiate	Buy
2021-03-02	Stifel	Initiate	Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date: Feb 13, 2023
Period: Q2 / 2023
EPS Estimate: -$0.19
Revenue Estimate
Revenue Q2Q: N/A
EPS Q2Q: 58.07%
Number of Analysts: 6

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

N/A

EPS (1 Month)

-8.82%

EPS (3 Months)

N/A

Next Earnings Summary

AGTC is expected to report earnings on 2/13/2023. The consensus EPS estimate for the next earnings is -0.19 USD and the consensus revenue estimate is 0 USD.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2020	2021	2022	2023	2024	2025	2026	2027
Revenue YoY % growth	2.45M -94.12%	500K -79.59%	325K -35.00%	51K -84.31%	77.265K 51.50%	11.434M 14,698.42%	631.27M 5,420.99%	18.09B 2,765.65%
EBITDA YoY % growth	-45.13M -1,365.26%	-55.355M -22.66%	-64.338M -16.23%	-70.278M -9.23%	-74.868M -6.53%	-72.93M 2.59%	-70.091M 3.89%	-68.709M 1.97%
EBIT YoY % growth	-46.47M -968.28%	-56.815M -22.26%	-65.85M -15.90%	-75.54M -14.72%	-80.655M -6.77%	-81.177M -0.65%	-76.633M 5.60%	-73.791M 3.71%
Operating Margin	-1,896.73%	-11,363.00%	-20,261.54%	-148,117.60%	-104,387.79%	-709.96%	-12.14%	-0.41%
EPS YoY % growth	-2.17 -1,872.73%	-1.88 13.36%	-1.54 18.09%	-0.94 38.73%	-0.73 22.70%	-1.04 -42.31%	-0.92 11.57%	-0.83 9.80%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q2 / 23	Q3 / 23	Q4 / 23	Q1 / 24	Q2 / 24	Q3 / 24	Q4 / 24	Q1 / 25	Q2 / 25
EPS Q2Q % growth	-0.19 58.07%	-0.11 66.00%	-0.12 66.00%	-0.12 56.29%	-0.12 35.14%	-0.41 -263.64%	-0.45 -266.67%	-0.46 -275.00%	-0.49 -300.00%
Revenue Q2Q % growth		N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Q2Q % growth	-17.85M -1.84%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Q2Q % growth	-21.581M -18.07%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

9.86%

EPS Next 5 Year

7.90%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

N/A

Revenue Next 5 Year

N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

-3.21%

EBIT Next 5 Year

-0.71%

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

APPLIED GENETIC TECHNOLOGIES / AGTC Forecast FAQ

Can you provide the average price target for APPLIED GENETIC TECHNOLOGIES stock?

10 analysts have analysed AGTC and the average price target is 0.37 USD. This implies a price decrease of -6.71% is expected in the next year compared to the current price of 0.3936.

Can you provide the upcoming earnings date for APPLIED GENETIC TECHNOLOGIES?

APPLIED GENETIC TECHNOLOGIES (AGTC) will report earnings on 2023-02-13.

What are the consensus estimates for AGTC stock next earnings?

The consensus EPS estimate for the next earnings of APPLIED GENETIC TECHNOLOGIES (AGTC) is -0.19 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed APPLIED GENETIC TECHNOLOGIES (AGTC)?

The number of analysts covering APPLIED GENETIC TECHNOLOGIES (AGTC) is 10.

Analyst forecast overview

Forecast Snapshot